This is a preview of subscription content, log in via an institution to check access.
Notes
Surveillance, Epidemiology, and End Results
Reference
Forde G, et al. Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage III C and IV epithelial ovarian cancer. ClinicoEconomics and Outcomes Research : 2 Aug 2016. Available from: URL: https://dx.doi.org/10.2147/CEOR.S91844
Rights and permissions
About this article
Cite this article
Is surgery more cost effective than chemo in advanced EOC?. PharmacoEcon Outcomes News 759, 19 (2016). https://doi.org/10.1007/s40274-016-3284-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3284-x